This article explores how the Food and Drug Administration (FDA) regulates dietary supplements, the challenges of ensuring quality control, and what consumers should know before purchasing dietary ...
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Maintaining cold chain compliance is crucial for protecting product integrity, worker safety, and minimizing costs, while ...
Beijing Tsingke Biotech Co., Ltd. officially announced the appointment of Dr. Yaning Wang, a former senior expert at the FDA, ...
FDA guidance followed in February 2012 ... This is the focus of biosimilar regulation. HB: One of the biggest challenges for start-up biotech companies is in understanding regulatory requirements ...
By Steven Grossman Secretary Kennedy’s announcement came last Thursday: FDA’s contribution to the pending HHS reduction in force (RIF) would ...
AI’s reach depends on the environments in which it operates as well as how it is developed and deployed, highlighting a ...
As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, ...
Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...
"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.
The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong ...
Layoffs of 10,000 Health and Human Services employees begin. Agencies devoted to seniors, minorities and HIV prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback